Arnav Aggarwal
@DrArnavAggarwal
Followers
115
Following
436
Media
2
Statuses
78
Gastroenterologist at AIIMS, New Delhi MD Medicine, PGI MBBS AIIMS, New Delhi #doctor #internist #Gastroenterologist
New Delhi, India
Joined October 2016
RT @DrDamandeep: #Throwback to an unforgettable day @aiims_newdelhi MBBS Convocation. AIIMS MBBS was once my dream—now my journey. Eager t….
0
4
0
RT @ebtapper: I regret to inform you that rifaximin did not improve survival in this RCT enrolling patients with cirrhosis and ascites http….
0
38
0
RT @JosephHabibi_MD: #CGH4ALL📣 💥.Injectable Naltrexone has an overall better GI and liver safety profile compared to other FDA-approved dru….
0
8
0
RT @JasmohanBajaj: Definitions of #liver failure vary➡️tower of Babel in #ACLF.Enter @CLEARED_liver with 🌎 input (>120 sites) @AGA_CGH .🔑 l….
0
29
0
RT @joseantonio83: New IBD classification. Florence classification @doc_ibd @IBDCedarsSinai #ECCO2025
0
115
0
RT @JustSagnik: Celebrating Shekhar completing his fellowship in Hepatology with flying colours! .@DrArnavAggarwal @drshalimar @Being_Med….
0
4
0
RT @HepCommJournal: 🚨 Next up in #GIHepFellowshipBootcamp, Management of #AUD‼️ 🍷 🍻 . You are seeing a patient in 🏥 with AUD, ✅ out this 📑….
0
12
0
RT @HepCommJournal: 📑 Patients with Cirrhosis and #AUDIT scores 8➕ have worse Liver Disease QoL scores‼️. Need to assess QoL ➡️ Identify de….
0
11
0
RT @stevenbollipo: I love reading my paper journals and occasionally find gems 💎 that I would have missed if I was reading things online. G….
0
5
0
RT @AmJGastro: Predicting and Preventing Bleeding in Patients With Cirrhosis Undergoing Procedures.Erno, et al. 📕 .
0
39
0
RT @AmJGastro: Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.Barritt, et al. 📕 @MLo….
0
20
0
RT @drkeithsiau: @medicosmcqs Wow, very good effort! I used to use this chart to help differentiate gastric polyps 👍
0
3
0
0
0
0
1
0
1
🧵6/.📌 Take-home message:. Low-dose steroids = ✅ similar efficacy. Lower (but not statistically significant) adverse effects. No difference in mortality or decompensation.
1
0
1
🧵5/.📉 Long-Term Outcomes:.📌 Rates of decompensation and mortality over extended follow-up were also similar 💯.✅ Low-dose doesn't compromise long-term efficacy.
1
0
0
🧵4/.🔍 Subgroup Spotlight:.🧫 Patients without cirrhosis had 🚀 higher response rates than those with cirrhosis.📉 Cirrhosis = lower response, regardless of steroid dose (🟢 or🔴).🧠 Important factor when tailoring AIH treatment plans! 👨⚕️👩⚕️.
1
0
0
🧵3/.⚠️ Side effects?. 🔴 High-dose had more 🚨 steroid-related issues (but not significant).
1
0
0
🧵2/ .At 6 months, both 🟢 low-dose & 🔴 high-dose steroids had 💯 similar response rates!. ⚖️ No advantage with high dose — same results, less baggage!.
1
0
0